Wanjia Group Holdings Limited (HKG:0401)
Hong Kong · Delayed Price · Currency is HKD 0.1100
0.00 (0.00%)
Jan 20, 2026, 3:34 PM HKT
Wanjia Group Holdings Market Cap
Wanjia Group Holdings has a market cap or net worth of 61.62 million as of January 21, 2026. Its market cap has increased by 120.00% in one year.
Market Cap
61.62M
Enterprise Value
55.04M
Revenue
163.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since October 11, 2013, Wanjia Group Holdings's market cap has decreased from 525.21M to 61.62M, a decrease of -88.27%. That is a compound annual growth rate of -16.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 61.62M | 10.00% |
| Dec 31, 2025 | 56.02M | 100.00% |
| Dec 31, 2024 | 28.01M | -41.18% |
| Dec 29, 2023 | 47.62M | -40.14% |
| Dec 30, 2022 | 79.55M | -11.25% |
| Dec 31, 2021 | 89.64M | 37.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 249.91B |
| JD Health International | 212.13B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 148.05B |
| Sino Biopharmaceutical | 116.56B |
| CSPC Pharmaceutical Group | 111.36B |
| Akeso | 108.05B |